Watchlist

Watchlist
Aevi Genomic Medicine, Inc. (GNMX)
Aevi Genomic Medicine, Inc. (GNMX)
Evaluating KemPharm's KP415, Part 2: The History Of ADHD Treatment And The Competitive Landscape
Introduction Porter's Five Forces analysis , first published in 1979, is a framework for thinking about a product's competitive landscape that I'm sure most investors have heard of, or if not, something they understand intuitively: KemPharm's ( KMPH ) KP415 may soon join a hefty mix of ADHD…
Aevi Genomic Medicine, Inc. (GNMX)